What is the recommended streptomycin dose, route, and duration for adults and children, including adjustments for weight, renal impairment, and infection type?

Streptomycin Dosing Recommendations

Streptomycin should be dosed at 15 mg/kg daily (maximum 1 g) via intramuscular injection for adults, with dose reduction to 10 mg/kg daily (maximum 750 mg) for patients over 59 years of age, and frequency can be reduced to three times weekly after the initial month of treatment. 1

Route of Administration

• Intramuscular injection is the primary recommended route for streptomycin administration 1
• Intravenous administration is possible but requires verification that the specific streptomycin preparation is suitable for IV use 1
• Limited clinical experience supports IV administration for patients where IM injection is problematic, though this remains off-label 2, 3, 4

Adult Dosing by Age and Weight

Standard Adult Dosing (≤59 years)

• 15 mg/kg daily (usual maximum 1 g daily) 1
• Maximum can be increased in large muscular adults if clinically necessary 1
• After initial period (typically 1 month): reduce to 15 mg/kg three times per week 1

Elderly Patients (>59 years)

• 10 mg/kg daily (maximum 750 mg daily) 1
• After initial period: 15 mg/kg three times per week 1
• Age-related reduction accounts for decreased renal clearance and increased ototoxicity risk 1

Obesity Adjustment

• Use ideal body weight plus 40% of excess weight for markedly obese patients 1
• This adjustment reflects decreased distribution of streptomycin in adipose tissue 1

Pediatric Dosing

• 15 mg/kg daily (usual maximum 1 g daily) 1
• After initial period: 15 mg/kg three times per week 1
• Alternative dosing of 20-40 mg/kg daily (maximum 1 g) has been described for tuberculosis 1

Renal Impairment Adjustments

Critical adjustment required: Streptomycin clearance is almost exclusively renal, making dose modification essential in renal dysfunction 1

• 12-15 mg/kg two to three times per week for patients with renal failure 1
• For creatinine clearance <30 mL/min or hemodialysis patients: maintain the milligram dose at 12-15 mg/kg per dose but reduce frequency to 2-3 times weekly 1
• Administer after dialysis to facilitate directly observed therapy and avoid premature drug removal 1
• Mandatory pharmacist consultation for renal dosing adjustments 1

Duration and Frequency Adjustments

Initial Intensive Phase

• Daily dosing for the first month (usually 1 month) 1
• Some protocols use daily dosing for 2-4 months depending on infection severity 1

Continuation Phase

• Three times weekly dosing after initial period 1
• Frequency reduction depends on efficacy of other drugs in the regimen and culture conversion 1

Therapeutic Drug Monitoring

Target serum concentrations: 1

• Trough: <5 mg/L (ideally <10 μg/mL per CDC guidelines) 1
• Peak: 25-35 mg/L (or 20-35 μg/mL) 1

Monitoring Schedule

• Peak level in first week, repeat if poor clinical response 1
• Trough levels: weekly for 4 weeks, then fortnightly for 4 weeks, then monthly if stable 1
• Adjust dose and/or frequency based on serum concentrations 1

Sample Timing

• Predose for trough 1
• 60 minutes after infusion ends for peak 1

Essential Safety Monitoring

Renal Function Monitoring

• Month 1: twice weekly 1
• Month 2: weekly 1
• Month 3 onwards: every 2 weeks until aminoglycoside cessation 1
• Increase monitoring frequency if renal impairment develops 1

Ototoxicity Monitoring

• Baseline audiometry before treatment initiation 1
• Monthly audiometry throughout aminoglycoside treatment 1
• Final audiometry 2 months after last dose 1
• Ototoxicity defined as: 20 dB loss at any one frequency OR 10 dB loss at two adjacent frequencies 1
• Monitor for vestibular symptoms (vertigo, loss of balance) and auditory disturbances 1

Special Infection-Specific Considerations

Enterococcal Endocarditis (Streptomycin-Susceptible/Gentamicin-Resistant)

• 15 mg/kg ideal body weight per 24 hours IV or IM in 2 equally divided doses 1
• Duration: 4-6 weeks depending on native vs. prosthetic valve 1
• Adjust to obtain peak 20-35 μg/mL and trough <10 μg/mL 1
• Requires rapid availability of streptomycin serum concentrations 1

Tuberculosis

• Standard dosing as above applies 1
• Higher intermittent doses maximize peak concentration:MIC ratio and may improve outcomes 5

Critical Drug Interactions

• Increased nephrotoxicity risk: capreomycin, cephalosporins, ciclosporin, colistimethate sodium, tacrolimus 1
• Increased ototoxicity risk: loop diuretics (furosemide, ethacrynic acid) 1
• Hypocalcemia risk: bisphosphonates 1
• Neuromuscular blockade: muscle relaxants may cause postoperative respiratory weakness 1

Absolute Contraindications

• Pregnancy: streptomycin is contraindicated due to risk of fetal hearing loss 1

Common Pitfalls to Avoid

• Do not use standard adult doses in elderly patients without age-based reduction—ototoxicity risk increases significantly with age 1
• Do not dose obese patients on actual body weight—use adjusted body weight calculation to avoid toxicity 1
• Do not continue daily dosing beyond initial period when three times weekly is appropriate—cumulative toxicity risk increases above 100-120 g total dose 1
• Do not skip therapeutic drug monitoring in renal impairment—serum concentrations are essential to balance efficacy and toxicity 1
• Do not assume IM absorption is reliable in hypoperfused patients—consider IV route in hemodynamically unstable patients 4